Pantoprazol Reig Jofre (Pantoprazole)

Pantoprazole selectively blocks the H+/K+‑ATPase enzyme, also known as the gastric proton pump, in the stomach’s parietal cells. By inhibiting this final step of acid secretion, it raises gastric pH and reduces the amount of acid that contacts the lining of the stomach and oesophagus.

The dosage of Pantoprazol Reig Jofre is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. The prescriber will set the appropriate strength, frequency and duration according to current clinical guidelines.

Pantoprazole is classified as pregnancy category B in many regions, indicating no evidence of risk in animal studies but limited human data. It should be used during pregnancy or lactation only if clearly needed after a careful risk‑benefit assessment by the healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Pantoprazole belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, it has a similar efficacy profile but may have fewer drug‑interaction concerns with certain antiplatelet agents.

Store Pantoprazol Reig Jofre at temperatures below 25 °C in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain potency throughout its shelf life.

The product is supplied as oral tablets that are taken with water, usually before a meal. Patients should follow the prescribing clinician’s instructions regarding timing, whether the tablet should be swallowed whole or can be dispersed, and the length of therapy.

Serious adverse events, though uncommon, include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated colitis, low magnesium levels, and increased risk of bone fractures with long‑term use. Any signs of these conditions require immediate medical evaluation.

Pantoprazol Reig Jof should be avoided in patients with known hypersensitivity to pantoprazole or other proton pump inhibitors. Caution is also advised for individuals with severe liver disease, those taking clopidogrel, and patients who are pregnant or breastfeeding unless the benefit outweighs the risk.